Saudi Arabia Mycoplasma Testing Market Size & Outlook
Related Markets
Saudi Arabia mycoplasma testing market highlights
- The Saudi Arabia mycoplasma testing market generated a revenue of USD 6.9 million in 2023 and is expected to reach USD 12.4 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Mycoplasma testing market data book summary
| Market revenue in 2023 | USD 6.9 million |
| Market revenue in 2030 | USD 12.4 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Kits & Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.7% of the global mycoplasma testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa mycoplasma testing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 11.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mycoplasma Testing Market Scope
Mycoplasma Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| InvivoGen | View profile | 101-250 | Toulouse, Midi-Pyrenees, France, Europe | http://invivogen.com |
| ATCC | View profile | 501-1000 | Manassas, Virginia, United States, North America | https://www.atcc.org/en.aspx |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Asahi Kasei Corp | View profile | 48897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | http://www.asahi-kasei.co.jp |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Saudi Arabia mycoplasma testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 53.62% in 2023. Horizon Databook has segmented the Saudi Arabia mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia mycoplasma testing market can primarily be attributed to the various initiatives being undertaken by the government to expand biotechnology sector in the country. Organizations like the King Abdullah University of Science and Technology (KAUST) facilitate biotechnology R&D activities in Saudi Arabia. Key players are expanding in the country to capitalize on the increasing demand for cell biology-related products.
For instance, in November 2022, Sysmex opened its subsidiary in Saudi Arabia to cater to customers in the country. Furthermore, in January 2024, Qiagen expanded its business in Saudi Arabia by opening a headquarters in Riyadh. The company decided to expand in the region due to the increasing demand for infectious disease control. With increasing need for testing, mycoplasma testing services are also likely to be in demand due to QC protocols.
Furthermore, increasing private & public partnerships is further anticipated to boost the demand for cell culture products in Saudi Arabia. For instance, in October 2019, Saudi Arabian Investment Authority (SAGIA) signed an MOU with Korea’s GL Rapha Co. to manufacture biological drugs worth USD 320 million in the country. Key players in the country include Thermo Fisher Scientific, Merck KGaA, and others.
Reasons to subscribe to Saudi Arabia mycoplasma testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia mycoplasma testing market databook
-
Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia mycoplasma testing market size, by kits & reagents, 2018-2030 (US$M)
Saudi Arabia Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
